Using a proprietary system called Quadrix (with 100+ variables), Richard Moroney ranks the prospects for small caps in his Upside newsletter. A new buy is CYNOSURE.

Track Richards’s picks at:

http://trackthepros.com/stocks/category/1718

“Aesthetic laser device maker Cynosure represents an attractive health-care pick. The company’s products are used mainly in minimally invasive procedures to remove hair and rejuvenate skin.

“Cynosure has benefited from strong demand for Smartlipo, its new laser-assisted system for fat removal.

“Despite a weak economic backdrop, cosmetic procedures continue to be popular. According to the American Society of Plastic Surgeons, more than 1.8 million surgical procedures were performed in 2007, including 302,000 liposuctions — the second most common cosmetic surgery.

“Roughly 10 million minimally-invasive procedures were performed, with some 900,000 laser hair-removal procedures. Consensus estimates project 2008 earnings of $1.91, up 33%.

“While likely to be volatile and sensitive to concerns regarding consumer spending, the stock qualifies as a Buy based on its strong operating

“For more than a decade, IBM lived up to its reputation as a slow-growing, stodgy company,” says Richard Moroney. The editor of the blue chip advisory, Dow Theory Forecasts , contends, “But over the last 12 months, the picture changed. Strong operating momentum is now propelling genuine operational growth despite US economic weakness.

Track Richard’s picks at:

http://trackthepros.com/categories.php?category_id=261

“Acquisitions and cost cuts have accounted for most of IBM’s growth in recent years. In the 10 years ended 2006, sales increased at an annualized rate of less than 2%, and the company lost both market share and influence.

“However, sales growth has accelerated in each of the last three quarters, and per-share profi ts have risen at least 23% in each period. Consensus estimates, trending upward over the last month, project per-share-profit growth of 24% in 2008 and 11% in 2009. IBM is a Focus List Buy and a Long-Term Buy.

“A broad